Truist on Chemours (CC): 'Operational Headwinds Guided to Drive 2Q Miss but TSS Earnings Robust'
Tweet Send to a Friend
Truist Securities analyst Peter Osterland reiterated a Buy rating and $20.00 price target on Chemours (NYSE: CC)The analyst comments "This ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
